CorePlus and AIxMED Revolutionize Bladder Cancer Detection with AI-Driven Technology CorePlus and AIxMED unveil an innovative AI-powered solution, AIxURO, enhancing bladder cancer diagnosis efficiency and accuracy, revolutionizing patient care.

CorePlus and AIxMED Revolutionize Bladder Cancer Detection with AI-Driven Technology #United_States #San_Juan #Bladder_Cancer #CorePlus #AIxMed

AIxMed Partners with PathNet to Revolutionize Urine Cytology through AI Technology Leading diagnostic innovators AIxMed and PathNet have teamed up to enhance urine cytology diagnostics using AI-powered solutions, promising improved accuracy and efficiency.

AIxMed Partners with PathNet to Revolutionize Urine Cytology through AI Technology #None #AIxMed #PathNet #AIxURO

AIxMed and Biopticka Laboratoř Collaborate to Advance Cytology in Europe with AI Technology AIxMed and Biopticka Laboratoř have announced a strategic partnership to enhance AI-driven urine cytology, aiming for improved cancer diagnosis in Europe.

AIxMed and Biopticka Laboratoř Collaborate to Advance Cytology in Europe with AI Technology #Czech_Republic #AIxMed #Biopticka #Cytology #Plzeň

AIxMed and CorePlus Collaborate on Advanced Digital Urine Cytology Workflow Solutions AIxMed and CorePlus have formed a partnership to enhance urinary cytology diagnostics with AI-driven quality control solutions, improving efficiency and consistency.

AIxMed and CorePlus Collaborate on Advanced Digital Urine Cytology Workflow Solutions #USA #Santa_Clara #CorePlus #AIxMed #Urine_Cytology

Enhancing Diagnostic Accuracy: AIxMed and Lumea Partner for Urine Cytology Innovations The collaboration between AIxMed and Lumea introduces AI-driven improvements to urine cytology, advancing bladder cancer diagnostics. Explore the innovations that are set to change clinical practices.

Enhancing Diagnostic Accuracy: AIxMed and Lumea Partner for Urine Cytology Innovations #USA #Santa_Clara #Lumea #AIxMed #Urine_Cytology